The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.

Roy AA, Pandey A, Dhas N, Hegde MM, Parekh HS, Andugulapati SB, Nandakumar K, Satish Rao BS, Mutalik S.

Open source

DOI
10.1155/adpp/1847197
Published
2025-04-24
Container
Adv Pharmacol Pharm Sci
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/adpp/1847197,
  title = {The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.},
  author = {Roy AA and  Pandey A and  Dhas N and  Hegde MM and  Parekh HS and  Andugulapati SB and  Nandakumar K and  Satish Rao BS and  Mutalik S.},
  year = {2025},
  journal = {Adv Pharmacol Pharm Sci},
  doi = {10.1155/adpp/1847197},
  url = {https://doi.org/10.1155/adpp/1847197}
}

RIS

TY  - JOUR
TI  - The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.
AU  - Roy AA
AU  -  Pandey A
AU  -  Dhas N
AU  -  Hegde MM
AU  -  Parekh HS
AU  -  Andugulapati SB
AU  -  Nandakumar K
AU  -  Satish Rao BS
AU  -  Mutalik S.
PY  - 2025
JO  - Adv Pharmacol Pharm Sci
DO  - 10.1155/adpp/1847197
UR  - https://doi.org/10.1155/adpp/1847197
ER  - 

APA

AA, R., A, P., N, D., MM, H., HS, P., SB, A., K, N., BS, S. R., & S., M. (2025). The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.. Adv Pharmacol Pharm Sci. https://doi.org/10.1155/adpp/1847197

Source records